- Home
- MEC vs ESPR Comparison
MEC vs ESPR Comparison
Compare MEC & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEC
- ESPR
- Stock Information
- Founded
- MEC 1945
- ESPR 2008
- Country
- MEC United States
- ESPR United States
- Employees
- MEC N/A
- ESPR N/A
- Industry
- MEC Industrial Specialties
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- MEC Industrials
- ESPR Health Care
- Exchange
- MEC Nasdaq
- ESPR Nasdaq
- Market Cap
- MEC 324.5M
- ESPR 305.0M
- IPO Year
- MEC 2019
- ESPR 2013
- Fundamental
- Price
- MEC $14.46
- ESPR $1.61
- Analyst Decision
- MEC Strong Buy
- ESPR Buy
- Analyst Count
- MEC 3
- ESPR 7
- Target Price
- MEC $20.67
- ESPR $6.36
- AVG Volume (30 Days)
- MEC 127.3K
- ESPR 4.2M
- Earning Date
- MEC 03-04-2025
- ESPR 03-04-2025
- Dividend Yield
- MEC N/A
- ESPR N/A
- EPS Growth
- MEC 226.32
- ESPR N/A
- EPS
- MEC 1.24
- ESPR N/A
- Revenue
- MEC $581,604,000.00
- ESPR $332,314,000.00
- Revenue This Year
- MEC $4.91
- ESPR $5.51
- Revenue Next Year
- MEC $1.59
- ESPR $1.42
- P/E Ratio
- MEC $11.55
- ESPR N/A
- Revenue Growth
- MEC N/A
- ESPR 185.66
- 52 Week Low
- MEC $12.75
- ESPR $1.47
- 52 Week High
- MEC $23.02
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- MEC 43.88
- ESPR 48.04
- Support Level
- MEC $14.00
- ESPR $1.47
- Resistance Level
- MEC $14.47
- ESPR $1.61
- Average True Range (ATR)
- MEC 0.70
- ESPR 0.13
- MACD
- MEC 0.04
- ESPR 0.01
- Stochastic Oscillator
- MEC 61.47
- ESPR 51.28
About MEC Mayville Engineering Company Inc.
Mayville Engineering Co Inc is involved in a manufacturing partner that provides a broad range of prototyping and tooling, production fabrication, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.